Scholar Rock Holding (SRRK) EBITDA Margin Growth (1y) (2020 - 2022)
Powered by 
Analysis
Scholar Rock Holding (SRRK) EBITDA Margin Growth (1y) (2020 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -1,651.00 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 29,091.00 |
| 10 | Scholar Rock Holding | 7.25 Bn | 7.25 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 55,700.00 |
| Dec 31, 2021 | -11,368.00 |
| Sep 30, 2021 | 9,911.00 |
| Jun 30, 2021 | -15,980.00 |
| Mar 31, 2021 | -22,612.00 |
| Dec 31, 2020 | -59,668.00 |
| Sep 30, 2020 | -41,936.00 |
| Jun 30, 2020 | -23,338.00 |
| Mar 31, 2020 | 2,502.00 |